Zimmer Biomet Holdings Inc (NYSE:ZBH) currently has a daily average trading volume of 1.51M but it saw 1461977 shares traded in last market. With a market cap of 21.75B USD, the company’s current market price of $109.27 came falling about -1.51 while comparing to the previous closing price of $110.95. In past 52 weeks, the stock remained buoying in the range of price level as high as $133.90 and as low as $101.47. In the recent trading on the day, stock has struck highest price mark of $109.08 while lowest mark touched by it was $110.81.
Taking a look at 20-day trading activity of Zimmer Biomet Holdings Inc (ZBH) gives us an average price of $108.31, while its current price level is -18.39% below from 52-week high level whereas it is 7.69% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $106.64 while that of 200 days or SMA-200 reads an average of $114.51. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.34% during that period while stretching the period over a month that decreases to 1.98%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.60 which implies that the stock is in neutral territory.
Piper Sandler downgraded its recommendation for the stock as a “Neutral” from “Overweight” on July 01, 2024 while assigning a price target range of $140-$115. Goldman also issued its recommendations for the stock as it initiated the price target for the stock is $129.
Over the week, ZBH’s stock price is moving -0.64% down while it is 4.81% when we observe its performance for the past one month. Year-to-date it is -10.21% down and over the past year, the stock is showing a downside performance of -2.87%.
Currently, Zimmer Biomet Holdings Inc’s total number of outstanding shares is 205.60M. Company’s return on investment (ROI) stands at 6.33% and return on equity (ROE) at 8.71%. It has a price to earnings ratio (P/E ratio) of 20.82 while having a 12.72 of forward P/E ratio. Stock’s beta reads 1.02. Stock has a price to book (P/B) ratio of 1.76 while price to sale or P/S ratio amounts to 2.86. Its return on asset (ROA) is 5.05% on average.
